17th December 2019 – Global Hyaluronic
Acid Market is expected to reach USD 15.4 billion by 2025. Hyaluronic
acid is also termed as hyaluronan or HA, is an organic compound that fits the
branch of carbohydrates and further to its polysaccharides segment. HA is
prepared in laboratory by numerous procedures, which includes extraction from
rooster combs, in-vitro and bacterial production.
It is a non-sulfated glycosaminoglycan,
which is present in the connective, neural and epithelial tissues of living
organisms. Due to its hydrophilic nature, hyaluronic acid is used as lubricants
and shock absorbers in various joint disorders, including osteoarthritis. The
Hyaluronic Acid Market is estimated to grow at a significant CAGR of 8.8% over
the forecast period as the scope and its applications are rising enormously
across the globe.
The rapid growth of aging population
coupled with significant increase of the disease conditions such as ulcers,
osteoarthritis, and dry are documented as major factors of Hyaluronic Acid
industry that are estimated to enhance the growth in the years to come. On the
other hand, allergic reactions, other cost effective treatments along with
several regulations concerns could act as restraints in the growth of global
Hyaluronic Acid. Hyaluronic Acid Market is segmented based on product type, end
user, and region.
Get
a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/hyaluronic-acid-market/request-sample
Single Injection, Three Injection, Five
Injection, and other product types could be explored in Hyaluronic Acid in the
forecast period. Three-injection cycle accounted for the substantial market
share of Hyaluronic Acid and is expected to gain popularity over the forecast
period. The dose is injected into synovial fluid of knee and hip to ease
movement and improve joint pain. These doses are taken in the span of 3 to 5
weeks depending on the condition and severity of the disease.
Single injection cycle is expected to be
the fastest growing segment with a highest CAGR in the coming years. This is
accredited to the preference of patients to short duration of treatment and
quick results. In 2016, Genzyme Corporation received the FDA approval for its
single injection treatment regimen, Synvisc-One. The product contains
high-molecular-weight polymers that act as a lubricant and reduce pain due to
osteoarthritis.
The market may be categorized based on
applications like Osteoarthritis, Opthalmic, Dermal Fillers, Vesicoureteral
Reflux, and others that could be explored in Hyaluronic Acid in the forecast
period. Dermal fillers accounted for the significant market share of the global
hyaluronic acid industry and is expected to lead the market over forecast
period.
Vesicoureteral Reflux segment is
expected to grow at the highest CAGR over the forecast period. This is because
of the change in lifestyle, injuries, and increased rate of surgeries
performed. Endoscopic treatment with HA injection is gaining popularity as a
treatment option. Ophthalmology market sector is expected to witness increasing
demand over the forecast period. This is mainly due to the increasing incidence
of diseases such as cataracts, glaucoma, age-related macular degeneration and
dry eyes.
Globally, North America accounted for
the substantial market share of the global Hyaluronic Acid Market in terms of
revenue and is expected to remain dominant over the forecast period. The U.S.
is the most important market and accounts for majority share of North America.
The population in this region is more conscious about aging and is open to
adopt new treatment methods.
Instead, Europe and the Asia Pacific are
also estimated to have a positive influence on the future growth. Europe is the
second largest region with significant market share. However, Asia Pacific is
estimated to grow at fastest pace with the highest CAGR in the foremost period.
Japan is one of the highest contributors to the Asia Pacific revenue, due to
its large geriatric population and growing awareness amongst people about
aesthetics.
The key players of hyaluronic acid
industry are Allergan, Anika Therapeutics, Sanofi (Genzyme), Salix
Pharmaceuticals, Dentsply International, Seikagaku Corporation, F. Hoffmann-La
Roche, GaldermaS.A, Zimmer Holdings, Smith & Nephew Plc, and Ferring
Pharmaceuticals. These players are concentrating on inorganic growth to sustain
themselves amongst fierce competition. As companies all over the world have to
believe that alliance with a market would permit them proportional market
existence and authority to declare the leadership position.
Get
in touch
At Million Insights, we work with the
aim to reach the highest levels of customer satisfaction. Our representatives
strive to understand diverse client requirements and cater to the same with the
most innovative and functional solutions.
For
More Information, Visit @ https://www.millioninsights.com
No comments:
Post a Comment